Evidence map›Paper›PMID 36093156›Full record

ArticleFrontiers in cardiovascular medicine2022

Active Tracking-based cardiac triggering for MR-thermometry during radiofrequency ablation therapy in the left ventricle.

Ronald Mooiweer, Rainer Schneider, Axel Joachim Krafft, Katy Empanger, Jason Stroup, Alexander Paul Neofytou, Rahul K Mukherjee, Steven E Williams, Tom Lloyd, Mark O'Neill and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Feasibility of cardiac MR thermometry at 0.55 T.Frontiers in cardiovascular medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Ronald MooiweerSchool of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Rainer SchneiderSiemens Healthcare GmbH, Erlangen, Germany.
Axel Joachim KrafftSiemens Healthcare GmbH, Erlangen, Germany.
Katy EmpangerImricor Medical Systems, Burnsville, MN, United States.
Jason StroupImricor Medical Systems, Burnsville, MN, United States.
Alexander Paul NeofytouSchool of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Rahul K MukherjeeSchool of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Steven E WilliamsSchool of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Tom LloydImricor Medical Systems, Burnsville, MN, United States.
Mark O'NeillSchool of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Reza RazaviSchool of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Tobias SchaeffterSchool of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Radhouene NejiSchool of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Sébastien RoujolSchool of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
King's College London · GBImricor (United States) · USSiemens Healthcare (Germany) · DESiemens (United Kingdom) · GB

Funding

British Heart Foundation PG/19/11/34243British Heart Foundation PG/21/10539
6 · The paper itself

Abstract

Cardiac MR thermometry shows promise for real-time guidance of radiofrequency ablation of cardiac arrhythmias. This technique uses ECG triggering, which can be unreliable in this situation. A prospective cardiac triggering method was developed for MR thermometry using the active tracking (AT) signal measured from catheter microcoils. In the proposed AT-based cardiac triggering (AT-trig) sequence, AT modules were repeatedly acquired to measure the catheter motion until a cardiac trigger was identified to start cardiac MR thermometry using single-shot echo-planar imaging. The AT signal was bandpass filtered to extract the motion induced by the beating heart, and cardiac triggers were defined as the extremum (peak or valley) of the filtered AT signal. AT-trig was evaluated in a beating heart phantom and

Indexed as

active trackingcardiac triggeringECGMR-thermometryRF ablation

Identifiers

PMID36093156
PMCPMC9453599
OpenAlexW4293088889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.